Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biote (BTMD) Invested Capital (2021 - 2025)

Biote (BTMD) has 5 years of Invested Capital data on record, last reported at -$59.2 million in Q3 2025.

  • For Q3 2025, Invested Capital rose 53.27% year-over-year to -$59.2 million; the TTM value through Sep 2025 reached -$59.2 million, up 53.27%, while the annual FY2024 figure was -$95.9 million, 216.71% down from the prior year.
  • Invested Capital reached -$59.2 million in Q3 2025 per BTMD's latest filing, up from -$72.6 million in the prior quarter.
  • Across five years, Invested Capital topped out at $10.7 million in Q1 2022 and bottomed at -$141.4 million in Q2 2024.
  • Average Invested Capital over 5 years is -$53.3 million, with a median of -$59.2 million recorded in 2025.
  • The widest YoY moves for Invested Capital: up 201.52% in 2022, down 4674.35% in 2022.
  • A 5-year view of Invested Capital shows it stood at $9.1 million in 2021, then crashed by 670.13% to -$52.0 million in 2022, then soared by 41.77% to -$30.3 million in 2023, then crashed by 216.71% to -$95.9 million in 2024, then soared by 38.28% to -$59.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were -$59.2 million in Q3 2025, -$72.6 million in Q2 2025, and -$78.6 million in Q1 2025.